The prophylactic effect of adding magnesium to metoral in reducing coronary AF
- Conditions
- All CABG candidate patients referred to Amirul Mominin Hospital.Complications of cardiac and vascular prosthetic devices, implants and grafts
- Registration Number
- IRCT20240527061915N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 102
All CABG candidate patients referred to Amirul Mominin Arak Hospital
All patients candidates for elective operations
The age of patients between 35-75 years
All patients are candidates for CABG only
All patients who are operated with that pump
All patients with informed consent to participate in this study
The average duration of surgery is maximum 7 hours
All patients who do not have heart valve repair surgery with CABG
ASA?,? patients
Patients who are not allergic to Metoral-Magnesium
All patients who have acid-base disorders resistant to treatment before surgery
Patients who suffer cardio-respiratory arrest during surgery
Patients who do not agree to continue the study or cooperate
All CABG candidate patients who require valve repair during surgery
All patients who, after the induction of anesthesia, the surgeon decides to perform surgery with the pump OFF
All patients who have acid-base disorders resistant to treatment before surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of atrial fibrillation or other arrhythmias after surgery. Timepoint: 72 hours after the operation. Method of measurement: Monitoring and examination of patients will be used in open heart ICU.
- Secondary Outcome Measures
Name Time Method Mortality and morbidity rate of patients. Timepoint: 72 hours after the operation. Method of measurement: Monitoring and examination of patients in open heart ICU.